ArticleFrontiers in oncology2026

Real-world data on the clinical impact of molecular tumor boards in high- and low-grade serous ovarian cancer.

Fabian B T Kraus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.